SCHEMBL16618839

SCHEMBL16618839

CC[CH]c1cccc(F)c1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 10/20 0.60
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2D6 P10635 1/20 0.54
PKM P14618 1/20 0.54
MAPK1 P28482 1/20 0.54
THPO P40225 1/20 0.54
NPC1 O15118 1/20 0.54
CHRM5 P08912 1/20 0.54
GRM5 P41594 1/20 0.54
RAB9A P51151 1/20 0.54
BLM P54132 1/20 0.54
PMP22 Q01453 1/20 0.54
PTGS1 P23219 5/20 0.49
RELA Q04206 1/20 0.47
PTGS2 P35354 1/20 0.47
NQO2 P16083 1/20 0.46
ACHE P22303 1/20 0.44
FBP1 P09467 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16618844 0.87 NFE2L2 (0.56) NFE2L2CYP1A2CYP3A4CYP2D6PKM
SCHEMBL9431977 0.84 NFE2L2 (0.52) NFE2L2CYP1A2CYP3A4CYP2D6PKM
SCHEMBL2187122 0.83 ALDH1A1 (0.37) NFE2L2NPC1CHRM5RELAACHE
SCHEMBL23457236 0.82 NFE2L2 (0.60) NFE2L2CYP1A2CYP3A4CYP2D6PKM
SCHEMBL16167415 0.81 NFE2L2 (0.65) NFE2L2CYP1A2CYP3A4CYP2D6PKM
SCHEMBL256055 0.81 NFE2L2 (0.65) NFE2L2CYP1A2CYP3A4CYP2D6PKM
SCHEMBL1759603 0.80 NFE2L2 (0.58) NFE2L2CYP1A2CYP3A4CYP2D6PKM
SCHEMBL16950982 0.79 NFE2L2 (0.52) NFE2L2CYP1A2CYP3A4CYP2D6PKM
SCHEMBL16955931 0.79 NFE2L2 (0.47) NFE2L2CYP1A2CYP3A4CYP2D6PKM
SCHEMBL27617456 0.78 NFE2L2 (0.56) NFE2L2CYP1A2CYP3A4CYP2D6PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112867706-A MASP-2 inhibitors and methods of use 奥默罗斯公司 2021-05-28 CN claimed
CN-102633727-A Synthetic method of 2-methylthio-4-(4-fluorophenyl)-6-isopropyl-pyrimidin-5-methyl carbonate UNIV ZHEJIANG TECHNOLOGY 2012-08-15 CN claimed
CN-102026980-A Isoquinolinone derivatives as NK3 antagonists LUNDBECK & CO AS H 2011-04-20 CN claimed
CN-101679271-A Quinoline derivatives, pharmaceutical compositions containing them and their use in the treatment of central nervous system and peripheral diseases ASTRAZENECA AB 2010-03-24 CN claimed
CN-101679276-A Isoquinolinone derivatives as nk3 antagonists LUNDBECK & CO AS H 2010-03-24 CN claimed
CN-101626686-A 3-substituent-1, 2, 3-benzotriazinone compounds for improving glutaminic synaptic responses CORTEX PHARMA INC 2010-01-13 CN claimed
CN-101370782-A Alkylsulphonamide quinolines ASTRAZENECA AB (SE) 2009-02-18 CN claimed
CN-117964683-A MASP-2 inhibitors and methods of use 奥默罗斯公司 2024-05-03 CN disclosed
CN-117964684-A MASP-2 inhibitors and methods of use 奥默罗斯公司 2024-05-03 CN disclosed
CN-110358445-B Composition for forming water-repellent film and water-repellent film 信越化学工业株式会社 2022-06-17 CN disclosed
US-11118072-B2 Water repellent film-forming composition and water repellent film SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-09-14 US disclosed
EP-3553121-B1 WATER REPELLENT FILM-FORMING COMPOSITION AND WATER REPELLENT FILM SHINETSU CHEMICAL CO (JP) 2021-06-09 EP disclosed
CN-112867706-A MASP-2 inhibitors and methods of use 奥默罗斯公司 2021-05-28 CN disclosed
CN-102026980-A Isoquinolinone derivatives as NK3 antagonists LUNDBECK & CO AS H 2011-04-20 CN disclosed
CN-101679276-A Isoquinolinone derivatives as nk3 antagonists LUNDBECK & CO AS H 2010-03-24 CN disclosed
CN-101626686-A 3-substituent-1, 2, 3-benzotriazinone compounds for improving glutaminic synaptic responses CORTEX PHARMA INC 2010-01-13 CN disclosed
CN-101370782-A Alkylsulphonamide quinolines ASTRAZENECA AB (SE) 2009-02-18 CN disclosed
CN-100417636-C Optically active 1-(fluoro-, trifluoromethyl-or trifluoromethoxy-substituted phenyl) alkylamine n-monoalkyl derivatives and process for producing same CENTRAL GLASS CO LTD (JP) 2008-09-10 CN disclosed
CN-101128421-A Methods and compositions for treating amyloid-related diseases NEUROCHEM INTERNAT LTD (CH) 2008-02-20 CN disclosed
CN-1671647-A Optically active 1-(fluoro-, trifluoromethyl-or trifluoromethoxy-substituted phenyl) alkylamine n-monoalkyl derivatives and process for producing same CENTRAL GLASS CO LTD (JP) 2005-09-21 CN disclosed